If you would appreciate to receive an email when there is a significant update on the drugs associated with Brugada syndrome (e.g. drugs added, removed or with changed qualifications), please fill in this form.
When you would like us to stop sending you email updates, please click here
Most importantly, this mailing list includes updates of the patient letter, the letter which harbours all drugs on this site and can be given to patients and all of their health care provides (including specialists, general practitioners, dentists and pharmacists).
History of drug updates
- 2015, January 24: Allapinine and Ethacizine added to the avoid list, Bupropion added to the preferably avoid list and Bepridil added to the list with possible anti-arrhythmic properties
- 2014, April 25: Cannabis added to the avoid list
- 2014, February 16: Vernakalant added to the preferably avoid list
- 2013, October 10: Lamotrigine added to the preferably avoid list
- 2013, September 09: Clothiapine added to the preferably avoid list, Brompheniramine and Dasatinib added to the list of drugs not to be avoided
- 2012, February 13: Procaine added to the avoid list
- 2011, July 31: Oxcarbazepine added to the avoid list
- 2011, June 16: Paroxetine and Metoclopramide added to the preferably avoid list
- 2011, January 23: Tramadol added to the preferably avoid list
- 2010, June 13: Ketamine added to the preferably avoid list
- 2010, February 26: Diphenhydramine added to the preferably avoid list
- 2009, December 13: Dosulepine added to the preferably avoid list
- 2009, November 21: Fluvoxamine and Terfenadine/Fexofenadine added to the preferably avoid list
- 2009, September: Official publication in Heart Rhythm
- 2009, July 10: Online publication on Heart Rhythm website
- 2009, May: Website functional online